Ethics framework urged to manage conflicts of interest in medicine

June 13, 2012

A recent international study led by researchers from McGill University and the McGill University Health Centre (MUHC) examines the complex and controversial interplay of conflicts of interest between physician experts, medicine and the pharmaceutical or medical device industry. The results of the analysis, which are published in the Annals of Internal Medicine, aim to advance the management of conflicts of interest in medical guidelines.

"Over the last decade governments, medical specialty societies and academia have increasingly confronted an in the development of influential, independent, expert ," says lead author, Derek J. Jones of McGill University's Faculty of Law Research Group on Health and the Law.

According to the study, clinical practice guidelines (CPGs) on , mental disorders, flu and diabetes have been criticized, questioned or annulled because of Conflicts of Interest (COIs) issues in the US, Canada, France and . "Should physician experts who have, or had, financial relations with industry be included, excluded, or limited from the development of international clinical practice guidelines," Jones asks. "What if their expertise is rare, unique or essential?"

The interdisciplinary project developed and analyzed the impact of an ethics framework designed to manage COIs in an international CPG on gastroenterology. They found the initiative fruitful, if challenging. "Given the absence of uniform COI definitions, procedures or standards in the international arena, we found that an ethics framework helps to identify COIs, ethics issues, and COI management options in the process," explains Jones.

"We further sought to measure the impact of COIs on voting and discussing the CPG recommendations," explained Dr. Alan Barkun, corresponding author of the study and chief of gastroenterology at the MUHC and professor of medicine at McGill. "Our analysis of the COI management tool used revealed little impact on voting recommendations for the guideline and some impact on discussion. These important issues demand further analysis and initiatives."

The study thus recommends targeted research, the use of ethics frameworks, a financing model, and international and institutional policy initiatives to better manage in the development of future CPGs.

Explore further: Industry conflicts of interest are pervasive among medical guideline panel members

More information: "Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines," Annals of Internal Medicine.

Related Stories

Industry conflicts of interest are pervasive among medical guideline panel members

October 12, 2011
Researchers at Mount Sinai School of Medicine have found that conflicts of interest (COI) are prevalent and potentially underreported among individuals participating in the development of clinical practice guidelines, which ...

Doctoral student develops ethical guidelines for GPs

November 4, 2011
Malcolm Oswald, a doctoral student in Bioethics and Medical Jurisprudence in the School of Law, is a co-author of the new guide, entitled, Making Difficult Choices - Ethical Commissioning Guidance to General Practitioners. ...

New clinical practice guidelines on alcoholic liver disease published

April 19, 2012
EASL today announced the publication of a new clinical practice guideline (CPG) in the area of Alcoholic Liver Disease (ALD), bringing the number of CPGs published to date to eight.

Recommended for you

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.